Wockhardt Ltd — Capital/Financing Update 2022

Sep 5, 2022

==> picture [178 x 49] intentionally omitted <==

WOCK/SEC/SE/2022-23/037

5[th] September 2022

BSE LimitedCorporate Relations DepartmentP J Towers,Dalal StreetMumbai - 400 001Scrip Code: 532300		National Stock Exchange of India LimitedListing DepartmentExchange PlazaBandra Kurla Complex, Bandra (E),Mumbai - 400 051NSE Symbol– WOCKPHARMA

Dear Sir/ Madam,

Sub: Reaffirmation of Credit Rating

This is to inform you that CARE Ratings Limited (CARE Ratings) has reaffirmed the Company’s Ratings for:

1. Long-Term Bank Facilities (Fund Based) of ₹ 527.75 (Reduced from ₹ 700 Crores) as “CARE BBB-; Stable” ;

2. Short Term Bank Facilities (Non-Fund Based) of ₹ 171.20 Crores (Reduced from ₹ 307.80 Crores) as “CARE A3” ; and

3. Non-Convertible Debenture of Rs. 200 crore as “CARE BBB-; Stable”

4. Non-Convertible Debentures aggregating upto Rs. 50 crores as “ CARE BBB-; Stable”

The ratings were given, inter alia , after factoring in the tie-up with various global partners for supply of vaccines and respiratory antibiotic, diversified product portfolio spread across multiple therapeutic segments, accredited manufacturing facilities along with R&D-focused approach, established marketing network with global presence, improvement in total operating income and operating profit margins in FY22 and successful raising of funds through rights issue and NCD issue.

Thanking you,

For Wockhardt Limited

Debash Digitally signed by Debashis Dey Date: 2022.09.05 is Dey 12:10:36 +05'30' Debashis Dey Company Secretary

==> picture [112 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==